Shop Antibodies
Best Seller

Custom mRNA Synthesis


Item Cat No.: BCMRNA

Concentration: 1 mg/ml mRNA

Application: In vitro and In vivo

Reactivity: Human, Mouse, Rat

BiCell Scientific Inc’s mRNA synthesis service provides in vitro transcribed eukaryotic mRNA ranging from 100bp to 6kb and featuring 5′ capping and 3′ poly-A tailing.

Messenger RNA (mRNA) synthesis by in vitro transcription (IVT) is a cell-free process to produce RNA by T7 RNA polymerase reactions. Synthesized RNA such as mRNA is widely used in protein expression, vaccine production, animal transgenesis and many other applications.

BiCell Scientific Inc’s mRNA synthesis service utilizes linear plasmid DNA as template to synthesize mRNA that are 5′-end capped and 3′-end tailed with poly-A. BiCell Scientific Inc is able to achieve synthesis of mRNA length up to 6 kb and mRNA yield of up to 1 mg per μg of plasmid DNA.

  • Molecular cloning of custom gene sequence into pCMV-T7 vector.
  • Produce and purify plasmid DNA as template.
  • In vitro transcribe mRNA with T7 RNA polymerase, NTP mixture, and m7G(5′)ppp(5′)A RNA cap analog.
  • Gel purify synthesized mRNA and extract mRNA with phenol:chloroform.

Customers will receive the following deliverables at the end of each project:

  • Plasmid DNA expressing custom RNA sequence downstream of T7 promoter
  • Gel purified RNA of 100 μg to 1 mg scale

For Research Use Only. Not for use in clinical diagnostics.

Additional information

Synthesis scale

100 ug, 500 ug, 1 mg


There are no reviews yet.

Be the first to review “Custom mRNA Synthesis”

"I am really impressed with your approach. We tried multiple times previously to create monoclonal and polyclonal antibodies to claudin-2 and MLCK1. We have had limited success generating polyclonals and no success generating monoclonals. You have generated outstanding monoclonals to both. I look forward to continuing to work with you."

Jerrold R. Turner, M.D., Ph.D.

Brigham and Women’s Hospital | Harvard Medical School

"The polyclonal antibody you generated for KIAA0408 is stunning! KIAA0408 is a novel cilium molecule that has never been studied. So, clearly there will be a lot of demand for it as we have discovered a very interesting finding and the story will be published in a high impact journal. I am strongly inclined to generate monoclonal antibody for this protein too and we should think about patenting it."

Univ.-Prof. Jay Gopalakrishnan PhD

Heinrich-Heine-Universität | Universitätsklinikum Düsseldorf

"Your ARL13B antibody works beautifully!!! We’re so happy to have a cilia-specific antibody made in rat! I can send you high resolution images to be posted on your website."

Julie Craft Van De Weghe, PhD

School of Medicine | University of Washington

"The assay is a homophilic interaction mediated cell adhesion on purified protein (in this case, immobilized purified Pcdhga9 to Pcdhga9 expressed on cell surface). Compared to control, cell adhesion is reduced in the presence of Pcdhga9 monoclonal antibody supernatants!"

Divyesh Joshi, PhD

School of Medicine | Yale University

"The rabbit hybridoma supernatants of anti-APOBEC3 project are tested positive by ELISA, and we are very happy about it! We previously tried a company, Abclone. Their Project "A" has immune response that is <10,000 titer in antiserum, which would explain why there is no positive mAb after fusion. Their project "B" didn't have any immune response in rabbit."

Harshita B Gupta, PhD.

School of Medicine | UT Health San Antonio

"We have tested anti mouse T cell antiserum samples from both rabbits you sent to us.

They worked very well! Thank you!"

Victoria Gorbacheva, PhD.

School of Medicine | Cleveland Clinic

Contact us for questions or custom requests!